The Oncosearch | Oncotarget

Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic Research Paper

Vikas Dembla, Neeta Somaiah, Pedro Barata, Kenneth Hess, Siqing Fu, Filip Janku, Daniel D. Karp, Aung Naing, Sarina Anne Piha-Paul, Vivek Subbiah, Apostolia M. Tsimberidou, Kenna Shaw, Funda Meric-Bernstam, David S. Hong

Published Sep 4, 2018 · Vol. 9, No. 69 · pp. 33232-33243

miR-665 targets c-MYC and HDAC8 to inhibit murine neuroblastoma cell growth Research Paper

Nagindra Prashad

Published Sep 4, 2018 · Vol. 9, No. 69 · pp. 33186-33201

Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells Research Paper

Seyung S. Chung, Pranabananda Dutta, David Austin, Piwen Wang, Adam Awad, Jaydutt V. Vadgama

Published Aug 31, 2018 · Vol. 9, No. 68 · pp. 32943-32957

Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumors Research Paper

Lise Barlebo Ahlborn, Ida Viller Tuxen, Florent Mouliere, Savvas Kinalis, Ane Y. Schmidt, Kristoffer Staal Rohrberg, Eric Santoni-Rugiu, Finn Cilius Nielsen, Ulrik Lassen, Christina Westmose Yde, Olga Oestrup, Morten Mau-Sorensen

Published Aug 24, 2018 · Vol. 9, No. 66 · pp. 32570-32579

Quantitative screening of serum protein biomarkers by reverse phase protein arrays Research Paper

Zhizhou Kuang, Ruochun Huang, Zhimin Yang, Zhiqiang Lv, Xinyan Chen, Fuping Xu, Yu-Hua Yi, Jian Wu, Ruo-Pan Huang

Published Aug 24, 2018 · Vol. 9, No. 66 · pp. 32624-32641

A novel molecular mechanism for a long non-coding RNA PCAT92 implicated in prostate cancer Research Paper

Pushpinder Singh Bawa, Samathmika Ravi, Swagatika Paul, Bibha Chaudhary, Subhashini Srinivasan

Published Aug 21, 2018 · Vol. 9, No. 65 · pp. 32419-32434

Therapeutic targeting of Aurora A kinase in Philadelphia chromosome-positive ABL tyrosine kinase inhibitor-resistant cells Research Paper

Seiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, Kazuma Ohyashiki

Published Aug 21, 2018 · Vol. 9, No. 65 · pp. 32496-32506

Treatment-related toxicities of apatinib in solid tumors: a meta-analysis Meta-Analysis

Ling Peng, Xianghua Ye, Yun Hong, Junyan Zhang, Yongquan Dong, Qiong Zhao

Published Aug 14, 2018 · Vol. 9, No. 63 · pp. 32262-32270

Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended schedule for expected activity and safety and phase II study Research Paper

Gemma Bruera, Silvia Massacese, Stefania Candria, Antonio Galvano, Rosa Manetta, Aldo Victor Giordano, Sergio Carducci, Alessandra Di Sibio, Eugenio Ciacco, Antonio Russo, Enrico Ricevuto, on behalf of Oncology Network ASL1 Abruz, Italy

Published Aug 7, 2018 · Vol. 9, No. 61 · pp. 31861-31876

LEE011 and ruxolitinib: a synergistic drug combination for natural killer/T-cell lymphoma (NKTCL) Research Paper

Yan Ting Hee, Junli Yan, Dean Nizetic, Wee-Joo Chng

Published Aug 7, 2018 · Vol. 9, No. 61 · pp. 31832-31841

A Phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors Research Paper

Jordi Rodon, Giuseppe Curigliano, Jean-Pierre Delord, Wael Harb, Analia Azaro, Yu Han, Celine Wilke, Valerie Donnet, Dalila Sellami, Thaddeus Beck

Published Aug 3, 2018 · Vol. 9, No. 60 · pp. 31709-31718

The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma Research Paper

Daniel Jose GarcÃa-DomÃnguez, Lourdes Hontecillas-Prieto, Pablo RodrÃguez-NÃºÃ±ez, Guillem Pascual-Pasto, Monica Vila-Ubach, Rosa GarcÃa-MejÃas, MarÃa JosÃ© Robles, Oscar M. Tirado, Jaume Mora, Angel M. Carcaboso, Enrique de Ãlava

Published Jul 31, 2018 · Vol. 9, No. 59 · pp. 31397-31410

Follistatin-like protein 1 sustains colon cancer cell growth and survival Research Paper

Gerolamo Bevivino, Silvia Sedda, Eleonora FranzÃ¨, Carmine Stolfi, Antonio Di Grazia, Vincenzo Dinallo, Flavio Caprioli, Federica Facciotti, Alfredo Colantoni, Angela Ortenzi, Piero Rossi, Giovanni Monteleone

Published Jul 27, 2018 · Vol. 9, No. 58 · pp. 31278-31290

Spatial and temporal proteome dynamics of glioma cells during oncolytic adenovirus Delta-24-RGD infection Research Paper

Andrea GonzÃ¡lez-Morales, Aintzane Zabaleta, Elizabeth Guruceaga, Marta M. Alonso, Marc GarcÃa-Moure, JoaquÃn FernÃ¡ndez-Irigoyen, Enrique SantamarÃa

Published Jul 24, 2018 · Vol. 9, No. 57 · pp. 31045-31065

Selinexor reduces the expression of DNA damage repair proteins and sensitizes cancer cells to DNA damaging agents Research Paper

Trinayan Kashyap, Christian Argueta, Thaddeus Unger, Boris Klebanov, Sophia Debler, William Senapedis, Marsha L. Crochiere, Margaret S. Lee, Michael Kauffman, Sharon Shacham, Yosef Landesman

Published Jul 20, 2018 · Vol. 9, No. 56 · pp. 30773-30786

Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma Research Paper

Caroline Roelants, Sofia Giacosa, Catherine Pillet, RÃ©mi Bussat, Pierre Champelovier, Olivier Bastien, Laurent Guyon, Valentin Arnoux, Claude Cochet, Odile Filhol

Published Jul 10, 2018 · Vol. 9, No. 53 · pp. 30066-30078

Epigenetic activation of HORMAD1 in basal-like breast cancer: role in Rucaparib sensitivity Research Paper

Xian Wang, Ying Tan, Xixi Cao, Jin Ah Kim, Tianmeng Chen, Yiheng Hu, Matthew Wexler, Xiaosong Wang

Published Jul 10, 2018 · Vol. 9, No. 53 · pp. 30115-30127

Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11 Correction

Hironaga Satake, Yu Sunakawa, Yuji Miyamoto, Masato Nakamura, Hiroshi Nakayama, Manabu Shiozawa, Akitaka Makiyama, Kazuma Kobayashi, Yutaro Kubota, Misuzu Mori, Masahito Kotaka, Akinori Takagane, Masahiro Gotoh, Masahiro Takeuchi, Masashi Fujii, Wataru Ichikawa, Takashi Sekikawa

Published Jul 6, 2018 · Vol. 9, No. 52 · pp. 30023-30023

Anchorage-dependent multicellular aggregate formation induces a quiescent stem-like intractable phenotype in pancreatic cancer cells Research Paper

Yukiko Miyatake, Yusuke Ohta, Shunji Ikeshita, Masanori Kasahara

Published Jul 6, 2018 · Vol. 9, No. 52 · pp. 29845-29856

Inhibition of mTOR downregulates expression of DNA repair proteins and is highly efficient against BRCA2-mutated breast cancer in combination to PARP inhibition Research Paper

Rania El Botty, Florence Coussy, Rana Hatem, Franck Assayag, Sophie Chateau-Joubert, Jean-Luc Servely, Sophie Leboucher, Charles Fouillade, Sophie Vacher, BÃ©rengÃ¨re Ouine, AurÃ©lie Cartier, Leanne de Koning, Paul Cottu, Ivan BiÃ¨che, Elisabetta Marangoni

Published Jul 3, 2018 · Vol. 9, No. 51 · pp. 29587-29600

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic Research Paper

miR-665 targets c-MYC and HDAC8 to inhibit murine neuroblastoma cell growth Research Paper

Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells Research Paper

Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumors Research Paper

Quantitative screening of serum protein biomarkers by reverse phase protein arrays Research Paper

A novel molecular mechanism for a long non-coding RNA PCAT92 implicated in prostate cancer Research Paper

Therapeutic targeting of Aurora A kinase in Philadelphia chromosome-positive ABL tyrosine kinase inhibitor-resistant cells Research Paper

Treatment-related toxicities of apatinib in solid tumors: a meta-analysis Meta-Analysis

Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended schedule for expected activity and safety and phase II study Research Paper

LEE011 and ruxolitinib: a synergistic drug combination for natural killer/T-cell lymphoma (NKTCL) Research Paper

A Phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors Research Paper

The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma Research Paper

Follistatin-like protein 1 sustains colon cancer cell growth and survival Research Paper

Spatial and temporal proteome dynamics of glioma cells during oncolytic adenovirus Delta-24-RGD infection Research Paper

Selinexor reduces the expression of DNA damage repair proteins and sensitizes cancer cells to DNA damaging agents Research Paper

Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma Research Paper

Epigenetic activation of HORMAD1 in basal-like breast cancer: role in Rucaparib sensitivity Research Paper

Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11 Correction

Anchorage-dependent multicellular aggregate formation induces a quiescent stem-like intractable phenotype in pancreatic cancer cells Research Paper

Inhibition of mTOR downregulates expression of DNA repair proteins and is highly efficient against BRCA2-mutated breast cancer in combination to PARP inhibition Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic Research Paper

miR-665 targets c-MYC and HDAC8 to inhibit murine neuroblastoma cell growth Research Paper

Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells Research Paper

Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumors Research Paper

Quantitative screening of serum protein biomarkers by reverse phase protein arrays Research Paper

A novel molecular mechanism for a long non-coding RNA PCAT92 implicated in prostate cancer Research Paper

Therapeutic targeting of Aurora A kinase in Philadelphia chromosome-positive ABL tyrosine kinase inhibitor-resistant cells Research Paper

Treatment-related toxicities of apatinib in solid tumors: a meta-analysis Meta-Analysis

Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended schedule for expected activity and safety and phase II study Research Paper

LEE011 and ruxolitinib: a synergistic drug combination for natural killer/T-cell lymphoma (NKTCL) Research Paper

A Phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors Research Paper

The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma Research Paper

Follistatin-like protein 1 sustains colon cancer cell growth and survival Research Paper

Spatial and temporal proteome dynamics of glioma cells during oncolytic adenovirus Delta-24-RGD infection Research Paper

Selinexor reduces the expression of DNA damage repair proteins and sensitizes cancer cells to DNA damaging agents Research Paper

Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma Research Paper

Epigenetic activation of HORMAD1 in basal-like breast cancer: role in Rucaparib sensitivity Research Paper

Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11 Correction

Anchorage-dependent multicellular aggregate formation induces a quiescent stem-like intractable phenotype in pancreatic cancer cells Research Paper

Inhibition of mTOR downregulates expression of DNA repair proteins and is highly efficient against BRCA2-mutated breast cancer in combination to PARP inhibition Research Paper